Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $NRC vs $SRTA | Chartloom

Compare

$NRC vs $SRTA

National Research Corp · Strata Critical Medical Inc

NRC

National Research Corp

SRTA

Strata Critical Medical Inc

Compare $NRC vs $SRTA

Comparing National Research Corp and Strata Critical Medical Inc

NRCNational Research Corp

SRTAStrata Critical Medical Inc

NRCNational Research Corp

Market cap

$452M

P/E (TTM)

81.00x

Forward P/E (NTM)

21.29x

Forward P/S (NTM)

3.04x

Rev growth (TTM)

-0.2%

YTD performance

13.3%

52W performance

78.0%

FCF yield

4.8%

SRTAStrata Critical Medical Inc

Market cap

$370M

P/E (TTM)

9.17x

Forward P/E (NTM)

58.55x

Forward P/S (NTM)

1.16x

Rev growth (TTM)

18.8%

YTD performance

-13.2%

52W performance

-13.0%

FCF yield

-13.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

NRC

SRTA

Detailed metrics comparison

NRC

National Research Corp

SRTA

Strata Critical Medical Inc

Market Cap

NRC$452M

SRTA$370M

Enterprise Value

NRC$539M

SRTA$354M

Price

NRC$20.43

SRTA$4.28

P/E Ratio

NRC81.00x

SRTA9.17x

P/S Ratio

NRC3.23x

SRTA1.45x

EV/Sales

NRC3.85x

SRTA1.38x

EV/EBITDA

NRC23.06x

SRTA0.00x

P/B Ratio

NRC68.67x

SRTA1.43x

P/FCF Ratio

NRC20.90x

SRTAN/A

EV/FCF

NRC24.91x

SRTA-7.16x

PEG Ratio

NRCN/A

SRTAN/A

Forward P/E (NTM)

NRC21.29x

SRTA58.55x

Forward P/S (NTM)

NRC3.04x

SRTA1.16x

Revenue (TTM)

NRC$140M

SRTA$256M

Revenue Growth (YoY)

NRC-0.2%

SRTA18.8%

Forward Rev Growth

NRC8.3%

SRTA12.1%

Gross Margin (TTM)

NRC61.7%

SRTA-40.4%

Operating Margin (TTM)

NRC10.5%

SRTA0.0%

EBITDA Margin (TTM)

NRC16.7%

SRTA-79.9%

Net Margin (TTM)

NRC4.0%

SRTA15.7%

FCF Margin (TTM)

NRC15.5%

SRTA-19.3%

Net Income (TTM)

NRC$6M

SRTA$40M

FCF (TTM)

NRC$22M

SRTA$-49M

EPS (TTM)

NRC$0.25

SRTA$0.47

ROE (TTM)

NRC48.5%

SRTA14.3%

ROA (TTM)

NRC4.3%

SRTA12.2%

ROIC (TTM)

NRC6.2%

SRTA14.3%

Cash

NRC$3M

SRTA$16M

Debt

NRC$90M

SRTA$0

Net Cash/Debt

NRC$-87M

SRTA$16M

Current Ratio (TTM)

NRC0.65x

SRTA2.64x

Quick Ratio (TTM)

NRC0.50x

SRTA1.45x

Debt/Equity (TTM)

NRC13.75x

SRTA0.00x

Debt/Assets (TTM)

NRC0.0%

SRTA0.0%

Interest Coverage (TTM)

NRCN/A

SRTAN/A

Net Debt/EBITDA (TTM)

NRC0.00x

SRTA0.00x

Beta

NRC0.26

SRTA2.57

52W Performance

NRC78.0%

SRTA-13.0%

YTD Performance

NRC13.3%

SRTA-13.2%

% from 52W High

NRC-13.7%

SRTA-34.2%

% from 52W Low

NRC85.5%

SRTA8.4%

Asset Turnover (TTM)

NRC1.03x

SRTA0.78x

FCF Yield (TTM)

NRC4.8%

SRTA-13.4%

Earnings Yield (TTM)

NRC1.2%

SRTA10.9%

Dividend Yield (TTM)

NRC2.8%

SRTAN/A

Rule of 40

NRC15.2

SRTA-0.5

EV/GP/RG

NRC0.98

SRTAN/A

Ticker research

View NRC research View SRTA research

Metric	NRC National Research Corp	SRTA Strata Critical Medical Inc
Market & Valuation
Market Cap	$452M	$370M
Enterprise Value	$539M	$354M
Price	$20.43	$4.28
P/E Ratio	81.00x	9.17x
P/S Ratio	3.23x	1.45x
EV/Sales	3.85x	1.38x
EV/EBITDA	23.06x	0.00x
P/B Ratio	68.67x	1.43x
P/FCF Ratio	20.90x	N/A
EV/FCF	24.91x	-7.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	21.29x	58.55x
Forward P/S (NTM)	3.04x	1.16x
Revenue & Growth
Revenue (TTM)	$140M	$256M
Revenue Growth (YoY)	-0.2%	18.8%
Forward Rev Growth	8.3%	12.1%
Profitability
Gross Margin (TTM)	61.7%	-40.4%
Operating Margin (TTM)	10.5%	0.0%
EBITDA Margin (TTM)	16.7%	-79.9%
Net Margin (TTM)	4.0%	15.7%
FCF Margin (TTM)	15.5%	-19.3%
Net Income (TTM)	$6M	$40M
FCF (TTM)	$22M	$-49M
EPS (TTM)	$0.25	$0.47
ROE (TTM)	48.5%	14.3%
ROA (TTM)	4.3%	12.2%
ROIC (TTM)	6.2%	14.3%
Financial Health
Cash	$3M	$16M
Debt	$90M	$0
Net Cash/Debt	$-87M	$16M
Current Ratio (TTM)	0.65x	2.64x
Quick Ratio (TTM)	0.50x	1.45x
Debt/Equity (TTM)	13.75x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.26	2.57
52W Performance	78.0%	-13.0%
YTD Performance	13.3%	-13.2%
% from 52W High	-13.7%	-34.2%
% from 52W Low	85.5%	8.4%
Efficiency & Yields
Asset Turnover (TTM)	1.03x	0.78x
FCF Yield (TTM)	4.8%	-13.4%
Earnings Yield (TTM)	1.2%	10.9%
Dividend Yield (TTM)	2.8%	N/A
Other
Rule of 40	15.2	-0.5
EV/GP/RG	0.98	N/A
Ticker research	View NRC research	View SRTA research

Valuation

P/E Ratio

SRTA

9.17x

NRC

81.00x

P/S Ratio

SRTA

1.45x

NRC

3.23x

EV/FCF

SRTA

-7.16x

NRC

24.91x

Growth & revenue

Revenue Growth TTM

SRTA

18.8%

NRC

-0.2%

Forward Revenue Growth

SRTA

12.1%

NRC

8.3%

Profitability & performance

Gross Margin

NRC

61.7%

SRTA

-40.4%

ROE

NRC

48.5%

SRTA

14.3%

FCF Yield %

NRC

4.8%

SRTA

-13.4%

52-Week Performance

NRC

78.0%

SRTA

-13.0%

Detailed metrics comparison

NRC

National Research Corp

SRTA

Strata Critical Medical Inc

Market Cap

NRC$452M

SRTA$370M

Enterprise Value

NRC$539M

SRTA$354M

Price

NRC$20.43

SRTA$4.28

P/E Ratio

NRC81.00x

SRTA9.17x

P/S Ratio

NRC3.23x

SRTA1.45x

EV/Sales

NRC3.85x

SRTA1.38x

EV/EBITDA

NRC23.06x

SRTA0.00x

P/B Ratio

NRC68.67x

SRTA1.43x

P/FCF Ratio

NRC20.90x

SRTAN/A

EV/FCF

NRC24.91x

SRTA-7.16x

PEG Ratio

NRCN/A

SRTAN/A

Forward P/E (NTM)

NRC21.29x

SRTA58.55x

Forward P/S (NTM)

NRC3.04x

SRTA1.16x

Revenue (TTM)

NRC$140M

SRTA$256M

Revenue Growth (YoY)

NRC-0.2%

SRTA18.8%

Forward Rev Growth

NRC8.3%

SRTA12.1%

Gross Margin (TTM)

NRC61.7%

SRTA-40.4%

Operating Margin (TTM)

NRC10.5%

SRTA0.0%

EBITDA Margin (TTM)

NRC16.7%

SRTA-79.9%

Net Margin (TTM)

NRC4.0%

SRTA15.7%

FCF Margin (TTM)

NRC15.5%

SRTA-19.3%

Net Income (TTM)

NRC$6M

SRTA$40M

FCF (TTM)

NRC$22M

SRTA$-49M

EPS (TTM)

NRC$0.25

SRTA$0.47

ROE (TTM)

NRC48.5%

SRTA14.3%

ROA (TTM)

NRC4.3%

SRTA12.2%

ROIC (TTM)

NRC6.2%

SRTA14.3%

Cash

NRC$3M

SRTA$16M

Debt

NRC$90M

SRTA$0

Net Cash/Debt

NRC$-87M

SRTA$16M

Current Ratio (TTM)

NRC0.65x

SRTA2.64x

Quick Ratio (TTM)

NRC0.50x

SRTA1.45x

Debt/Equity (TTM)

NRC13.75x

SRTA0.00x

Debt/Assets (TTM)

NRC0.0%

SRTA0.0%

Interest Coverage (TTM)

NRCN/A

SRTAN/A

Net Debt/EBITDA (TTM)

NRC0.00x

SRTA0.00x

Beta

NRC0.26

SRTA2.57

52W Performance

NRC78.0%

SRTA-13.0%

YTD Performance

NRC13.3%

SRTA-13.2%

% from 52W High

NRC-13.7%

SRTA-34.2%

% from 52W Low

NRC85.5%

SRTA8.4%

Asset Turnover (TTM)

NRC1.03x

SRTA0.78x

FCF Yield (TTM)

NRC4.8%

SRTA-13.4%

Earnings Yield (TTM)

NRC1.2%

SRTA10.9%

Dividend Yield (TTM)

NRC2.8%

SRTAN/A

Rule of 40

NRC15.2

SRTA-0.5

EV/GP/RG

NRC0.98

SRTAN/A

Ticker research

View NRC research View SRTA research

Metric	NRC National Research Corp	SRTA Strata Critical Medical Inc
Market & Valuation
Market Cap	$452M	$370M
Enterprise Value	$539M	$354M
Price	$20.43	$4.28
P/E Ratio	81.00x	9.17x
P/S Ratio	3.23x	1.45x
EV/Sales	3.85x	1.38x
EV/EBITDA	23.06x	0.00x
P/B Ratio	68.67x	1.43x
P/FCF Ratio	20.90x	N/A
EV/FCF	24.91x	-7.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	21.29x	58.55x
Forward P/S (NTM)	3.04x	1.16x
Revenue & Growth
Revenue (TTM)	$140M	$256M
Revenue Growth (YoY)	-0.2%	18.8%
Forward Rev Growth	8.3%	12.1%
Profitability
Gross Margin (TTM)	61.7%	-40.4%
Operating Margin (TTM)	10.5%	0.0%
EBITDA Margin (TTM)	16.7%	-79.9%
Net Margin (TTM)	4.0%	15.7%
FCF Margin (TTM)	15.5%	-19.3%
Net Income (TTM)	$6M	$40M
FCF (TTM)	$22M	$-49M
EPS (TTM)	$0.25	$0.47
ROE (TTM)	48.5%	14.3%
ROA (TTM)	4.3%	12.2%
ROIC (TTM)	6.2%	14.3%
Financial Health
Cash	$3M	$16M
Debt	$90M	$0
Net Cash/Debt	$-87M	$16M
Current Ratio (TTM)	0.65x	2.64x
Quick Ratio (TTM)	0.50x	1.45x
Debt/Equity (TTM)	13.75x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.26	2.57
52W Performance	78.0%	-13.0%
YTD Performance	13.3%	-13.2%
% from 52W High	-13.7%	-34.2%
% from 52W Low	85.5%	8.4%
Efficiency & Yields
Asset Turnover (TTM)	1.03x	0.78x
FCF Yield (TTM)	4.8%	-13.4%
Earnings Yield (TTM)	1.2%	10.9%
Dividend Yield (TTM)	2.8%	N/A
Other
Rule of 40	15.2	-0.5
EV/GP/RG	0.98	N/A
Ticker research	View NRC research	View SRTA research